Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery

A Konvalinka, L Errett, I W Fong, A Konvalinka, L Errett, I W Fong

Abstract

Staphylococcus aureus is a common cause of postoperative wound infections, and nasal colonization by this organism is an important factor in the development of infections. Treatment with mupirocin can eradicate the organism in the short term, and prophylactic treatment of colonized patients may prevent postoperative S. aureus infections. A double-blind, randomized, placebo-controlled trial was performed to determine whether nasal mupirocin administered pre-operatively to S. aureus carriers reduces the rates of sternal and leg wound infections after cardiac surgery. The study enrolled 263 patients with nasal S. aureus undergoing elective cardiac surgery at St. Michael's Hospital, Toronto, Canada. Patients were assessed for infections in the immediate postoperative period and two months later. Two hundred and fifty-seven patients were included in the intention-to-treat analysis and re-analysed according to the actual treatment applied. Wound infections occurred in 17 (13.5%) mupirocin recipients and 11 (9.1%) placebo recipients (P=0.319), with seven (5.4%) and six (4.7%) sternal infections, respectively. Two (1.6%) wound infections were acquired postoperatively in the mupirocin group, neither of which were caused by S. aureus. The placebo group had three (2.4%) nosocomial wound infections, with two (1.6%) S. aureus bacteraemias (P=0.243). Among patients receiving mupirocin, 106 (81.5%) cleared S. aureus compared with 59 (46.5%) patients receiving placebo (P<0.0001). There was no significant difference between intention-to-treat and actual treatment groups. Prophylactic intranasal mupirocin administered to S. aureus carriers did not reduce the rates of overall surgical site infections by S. aureus, and only showed a trend towards decreased incidence of nosocomial S. aureus infections.

References

    1. Olson D., Lee J.T., Jr. Continuous 10 year wound infection surveillance: results, advantages, and unanswered questions. Arch Surg. 1990;125:794–803.
    1. Greenblatt J., Fisher R.A. Complications of cardiac surgery: infections. In: Kotler M.N., Alfieri A., editors. Cardiac and non-cardiac complications of open heart surgery: prevention, diagnosis, and treatment. Futura; New York: 1992. pp. 145–176.
    1. Sellick J.A., Jr., Stelmach M., Mylotte J.M. Surveillance of surgical wound infection following open heart surgery. Infect Control Hosp Epidemiol. 1991;12:591–596.
    1. Loop F.D., Lytle B.W., Cosgrove D.M. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity and cost of care. Ann Thorac Surg. 1990;49:179–187.
    1. Bor D.H., Rose R.M., Modlin J.F., Weintraub R., Friedland G.H. Mediastinitis after cardiovascular surgery. Rev Infect Dis. 1983;5:885–897.
    1. Demmy T.L., Park S.B., Liebler G.A. Recent experience with major sternal wound complications. Ann Thorac Surg. 1990;49:458–462.
    1. Culver D.H., Horan T.C., Gagnes R.P. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med. 1991;91(Suppl 3B):152S–157S.
    1. Grossi E.A., Culliford A.T., Kreiger K.H. A survey of 77 major infectious complications of median sternotomy: a review of 7949 consecutive operative procedures. Ann Thorac Surg. 1985;40:214–223.
    1. Sarr M.G., Gott V.L., Townsend T.R. Mediastinal infection after cardiac surgery. Ann Thorac Surg. 1984;38:415–423.
    1. L'Ecuyer P.B., Murphy D., Little J.R., Fraser V.J. The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis. 1996;22:424–429.
    1. Nelson R.M., Dries D.J. The economic implications of infection in cardiac surgery. Ann Thorac Surg. 1986;42:240–246.
    1. Boyce J.M., Potter-Bynoe G., Dziobec L. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol. 1990;11:89–93.
    1. Kirkland K.B., Briggs J.P., Trivette S.L., Wilkinson W.E., Sexton D.J. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–730.
    1. Fong I.W., Baker C.B., McKee D.C. The value of prophylactic antibiotics in aorta-coronary bypass operations: a double-blind randomized trial. J Thorac Cardiovasc Surg. 1979;78:908–913.
    1. Kluytmans J.A.J.W., Mouton J.W., Maat A.P.W.M., Manders M.A.A.J., Michel M.F., Wagenvoort J.H.T. Surveillance of post operative infections in thoracic surgery. J Hosp Infect. 1994;27:139–147.
    1. Perl T.M., Golub J.E. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother. 1998;32:S7–S16.
    1. Kluytmans J.A.J.W., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505–520.
    1. Wenzel R.P., Perl T.M. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. 1995;31:13–24.
    1. Laupland K., Church D., Mucenski M., Sutherland L., Davies H. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003;187:1452–1459.
    1. von Eiff C., Becker K., Machka K., Stammer H., Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344:11–16.
    1. Kluytmans J.A.J.W., Mouton J.W., Ijzeman E.P.F. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis. 1995;171:216–219.
    1. Fong IW, Laurel M, McMillan S, Bannatyne R. Association of Staphylococcus aureus nasal carriage with sternotomy wound infection. IDSA 33rd Annual Meeting, 16–18 September 1995, San Francisco, Abstract #63.
    1. Gilbert D.N., Moellering R., Sande M. 32nd edn. Antimicrobial Therapy Inc.; Hyde Park, VT: 2002. The Stanford guide to antimicrobial therapy.
    1. Fong IW, Alhesayen A, MacMillan S, Bannatyne R, Errett L. The value of treating S. aureus nasal carriers with mupirocin ointment on sternal infection after cardiac surgery. IDSA 34th Annual Meeting, 18–20 September 1996, New Orleans, Abstract #181.
    1. Boyce J.M. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect. 2001;48(Suppl):S9–S14.
    1. Chow J.W., Yu V.L. Staphylococcus aureus nasal carriage in hemodialysis patients: its role in infection and approaches to prophylaxis. Arch Intern Med. 1989;149:1258–1262.
    1. Herwaldt L.A. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients. J Hosp Infect. 1998;40(Suppl):S13–S23.
    1. Mody L., Kauffman C.A., McNeil S.A., Yapecki A.T., Bradley S.F. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37:1467–1474.
    1. Tacconelli E., Carmeli Y., Aizer A., Ferreira G., Foreman M.G., D'Agata E.M.C. Mupirocin prophylaxis to prevent Staphylococcus aureus infections in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37:1629–1638.
    1. Kluytmans J.A., Mouton J.W., VandenBergh M.F. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 1996;17:780–785.
    1. Cimochowski G.F., Harostock M.D., Brown R., Bernardi M., Alonzo N., Loyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg. 2001;71:1572–1579.
    1. Gernaat von der Sluis A.J., Hoogenboom-Verdegaal A.M., Edixhoven P.J., Spies-von Rooijen N.H. Prophylactic mupirocin could reduce orthopedic wound infections: 1044 patients treated with mupirocin compared with 1260 historical controls. Acta Orthop Scand. 1998;69:412–414.
    1. Perl T.M., Cullen J.J., Wenzel R.P. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871–1877.
    1. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis. 2002;35:353–358.
    1. Perez-Fontan M., Rosales M., Rodriguez-Carmona A., Falcon T.G., Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis. 2002;39:337–341.
    1. Pena C., Fernandez-Sabe N., Dominguez M.A. Staphylococcus aureus nasal carriage in patients on hemodialysis: role of cutaneous colonization. J Hosp Infect. 2004;58:20–27.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다